GB0305790D0 - Novel Composition - Google Patents

Novel Composition

Info

Publication number: GB0305790D0
Authority: GB; United Kingdom
Prior art keywords: novel composition; novel; composition
Prior art date: 2003-03-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0305790.8A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BIO INVENT INTERNAT AB

GlaxoSmithKline Biologicals SA

Original Assignee

BIO INVENT INTERNAT AB

GlaxoSmithKline Biologicals SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-13

Filing date

2003-03-13

Publication date

2003-04-16

2003-03-13 Application filed by BIO INVENT INTERNAT AB, GlaxoSmithKline Biologicals SA filed Critical BIO INVENT INTERNAT AB

2003-03-13 Priority to GBGB0305790.8A priority Critical patent/GB0305790D0/en

2003-04-16 Publication of GB0305790D0 publication Critical patent/GB0305790D0/en

2004-03-11 Priority to PCT/EP2004/002640 priority patent/WO2004081046A2/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

GBGB0305790.8A 2003-03-13 2003-03-13 Novel Composition Ceased GB0305790D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB0305790.8A GB0305790D0 (en)	2003-03-13	2003-03-13	Novel Composition
PCT/EP2004/002640 WO2004081046A2 (en)	2003-03-13	2004-03-11	Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0305790.8A GB0305790D0 (en)	2003-03-13	2003-03-13	Novel Composition

Publications (1)

Publication Number	Publication Date
GB0305790D0 true GB0305790D0 (en)	2003-04-16

Family

ID=9954729

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0305790.8A Ceased GB0305790D0 (en)	2003-03-13	2003-03-13	Novel Composition

Country Status (2)

Country	Link
GB (1)	GB0305790D0 (en)
WO (1)	WO2004081046A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CU23736A1 (en)	2009-05-04	2011-11-15	Centro Inmunologia Molecular	ANTIBODIES RECOGNIZING SULFATIDES AND SULFATED PROTEOGLYCANS AND THEIR USE
EP2332995A1 (en) *	2009-12-10	2011-06-15	Bayer Schering Pharma Aktiengesellschaft	Neutralizing prolactin receptor antibodies and their therapeutic use
US9783600B2 (en)	2013-02-25	2017-10-10	Imbp Holding, Llc	Apolipoprotein C3 (ApoCIII) antagonists and methods of their use to remove ApoCIII inhibition of lipoprotein lipase (LPL)
CN106810606A (en) *	2015-11-27	2017-06-09	西藏自治区人民医院	A kind of preparation and application of Apolipoprotein C-III antigen polypeptide and its polyclonal antibody
CA3030099A1 (en) *	2016-07-08	2018-01-11	Staten Biotechnology B.V.	Anti-apoc3 antibodies and methods of use thereof
MA50958A (en)	2017-04-21	2020-10-14	Staten Biotechnology B V	ANTI-APOC3 ANTIBODIES AND THEIR METHODS OF USE
JP7039694B2 (en)	2017-10-31	2022-03-22	スターテン・バイオテクノロジー・ベー・フェー	Anti-APOC3 antibody and how to use it
US10538583B2 (en)	2017-10-31	2020-01-21	Staten Biotechnology B.V.	Anti-APOC3 antibodies and compositions thereof
JP2022504287A (en) *	2018-10-03	2022-01-13	スターテン・バイオテクノロジー・ベー・フェー	Antibodies specific for human and cynomolgus monkey APOC3, and methods of their use
WO2021119482A1 (en)	2019-12-13	2021-06-17	Progenity, Inc.	Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001246493A1 (en) *	2000-03-03	2001-09-12	Smithkline Beecham Biologicals S.A.	Vaccine
GB0121171D0 (en) *	2001-08-31	2001-10-24	Glaxosmithkline Biolog Sa	Vaccine
EP1392732A2 (en) *	2001-06-05	2004-03-03	Genfit	Method for apo ciii measurement in apob and non apob containing particles

2003
- 2003-03-13 GB GBGB0305790.8A patent/GB0305790D0/en not_active Ceased
2004
- 2004-03-11 WO PCT/EP2004/002640 patent/WO2004081046A2/en active Application Filing

Also Published As

Publication number	Publication date
WO2004081046A2 (en)	2004-09-23
WO2004081046A3 (en)	2005-02-17

Publication	Publication Date	Title
GB0305941D0 (en)	2003-04-23	Composition
GB0302738D0 (en)	2003-03-12	Composition
GB0324918D0 (en)	2003-11-26	Composition
GB0203296D0 (en)	2002-03-27	Novel composition
EP1613352A4 (en)	2009-04-29	Micro-cluster compositions
GB0318824D0 (en)	2003-09-10	Novel composition
GB0324897D0 (en)	2003-11-26	Composition
GB0305790D0 (en)	2003-04-16	Novel Composition
GB0322033D0 (en)	2003-10-22	Composition
MY145151A (en)	2011-12-30	Composition
GB0300602D0 (en)	2003-02-12	Compositions
GB0309317D0 (en)	2003-06-04	Composition
GB0324574D0 (en)	2003-11-26	Novel compositions
GB0328023D0 (en)	2004-01-07	Novel compositions
GB0205786D0 (en)	2002-04-24	Novel Composition
GB0306312D0 (en)	2003-04-23	Composition
GB0404470D0 (en)	2004-03-31	Composition
GB0326815D0 (en)	2003-12-24	Composition
GB0311465D0 (en)	2003-06-25	Composition
GB0301869D0 (en)	2003-02-26	Composition
GB0302732D0 (en)	2003-03-12	Composition
GB0308260D0 (en)	2003-05-14	Composition
GB0320562D0 (en)	2003-10-01	Composition
GB0302739D0 (en)	2003-03-12	Composition
GB0318533D0 (en)	2003-09-10	Composition

Legal Events

Date	Code	Title	Description
2004-05-05	AT	Applications terminated before publication under section 16(1)